• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

近期发病的扩张型心肌病左心室功能恢复的流行病学及自然病程

Epidemiology and natural history of recovery of left ventricular function in recent onset dilated cardiomyopathies.

作者信息

Givertz Michael M, Mann Douglas L

机构信息

Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.

出版信息

Curr Heart Fail Rep. 2013 Dec;10(4):321-30. doi: 10.1007/s11897-013-0157-5.

DOI:10.1007/s11897-013-0157-5
PMID:24014141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3823811/
Abstract

Although the long term prognosis of patients with dilated cardiomyopathy (DCM) remains poor, approximately 25 % of DCM patients with recent onset of heart failure (< 6 months) have a relatively benign clinical course with a spontaneously improvement in symptoms and partial, or in some cases complete, recovery of left ventricular (LV) function. Despite the longstanding recognition of the clinical phenomenon of LV recovery, relatively little attention has been paid to the etiology and natural history of this important group of DCM patients. Accordingly, in the present review we will focus on the epidemiology and natural history of recent onset DCM in patients who undergo spontaneous resolution of symptoms that is accompanied by recovery of LV function.

摘要

尽管扩张型心肌病(DCM)患者的长期预后仍然很差,但约25%近期发生心力衰竭(<6个月)的DCM患者临床病程相对良性,症状可自发改善,左心室(LV)功能部分恢复,或在某些情况下完全恢复。尽管LV恢复这一临床现象早已为人所知,但对于这一重要的DCM患者群体的病因和自然病史却相对关注较少。因此,在本综述中,我们将聚焦于近期发生DCM且症状自发缓解并伴有LV功能恢复的患者的流行病学及自然病史。

相似文献

1
Epidemiology and natural history of recovery of left ventricular function in recent onset dilated cardiomyopathies.近期发病的扩张型心肌病左心室功能恢复的流行病学及自然病程
Curr Heart Fail Rep. 2013 Dec;10(4):321-30. doi: 10.1007/s11897-013-0157-5.
2
Dilated cardiomyopathy in a pediatric population: etiology and outcome predictors - a single-center experience.儿科人群中的扩张型心肌病:病因及预后预测因素——单中心经验
Future Cardiol. 2019 Mar;15(2):95-107. doi: 10.2217/fca-2018-0030. Epub 2019 Mar 8.
3
[Clinical polymorphic presentation and natural history of active myocarditis: experience in 60 cases].[活动性心肌炎的临床多形性表现及自然病程:60例经验]
G Ital Cardiol. 1997 Aug;27(8):758-74.
4
Frequency, prognosis and predictors of improvement of systolic left ventricular function in patients with 'classical' clinical diagnosis of idiopathic dilated cardiomyopathy.“经典”临床诊断为特发性扩张型心肌病患者左心室收缩功能改善的频率、预后及预测因素
Eur J Heart Fail. 2001 Jun;3(3):323-30. doi: 10.1016/s1388-9842(00)00150-1.
5
Predictors of Left Ventricular Functional Recovery and Their Impact on Clinical Outcomes in Patients With Newly Diagnosed Dilated Cardiomyopathy and Heart Failure.新诊断扩张型心肌病和心力衰竭患者左心室功能恢复的预测因素及其对临床结局的影响
Heart Lung Circ. 2018 Jan;27(1):41-49. doi: 10.1016/j.hlc.2017.02.013. Epub 2017 Mar 20.
6
Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy.不同病因对扩张型心肌病患者临床病程及预后的影响。
Eur J Clin Invest. 2015 Sep;45(9):906-17. doi: 10.1111/eci.12483. Epub 2015 Aug 6.
7
Left Atrial Volume as a Predictor of Left Ventricular Functional Recovery in Patients With Dilated Cardiomyopathy and Absence of Delayed Enhancement in Cardiac Magnetic Resonance.左心房容积作为扩张型心肌病且心脏磁共振无延迟强化患者左心室功能恢复的预测因子。
J Card Fail. 2016 Apr;22(4):265-71. doi: 10.1016/j.cardfail.2015.12.011. Epub 2015 Dec 14.
8
Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy.心肌内 miR-133a 水平与炎症性心肌病患者的心肌炎症、左心室功能改善和临床结局相关。
Eur J Heart Fail. 2016 Dec;18(12):1442-1451. doi: 10.1002/ejhf.579. Epub 2016 Jun 13.
9
Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy.糖尿病对非缺血性扩张型心肌病患者左心室纵向功能的影响。
Cardiovasc Diabetol. 2020 Jun 13;19(1):84. doi: 10.1186/s12933-020-01063-y.
10
[Multislice spiral computed tomography of the heart in dilated cardiomyopathy: possibilities in the verification of myocarditis (in comparison with myocardial biopsy) and in the evaluation of prognosis].扩张型心肌病的心脏多层螺旋计算机断层扫描:在心肌炎验证(与心肌活检比较)及预后评估中的应用可能性
Ter Arkh. 2017;89(12):15-27. doi: 10.17116/terarkh2017891215-27.

引用本文的文献

1
Potential Prognostic Impact of High-Sensitivity C-Reactive Protein in the Analysis of Whole-Heart Myocardial Mechanics and Morphometry: Prospective CMR-Based Study.高敏C反应蛋白在全心心肌力学与形态测量分析中的潜在预后影响:基于心脏磁共振成像的前瞻性研究
Clin Med Insights Cardiol. 2025 Sep 16;19:11795468251369240. doi: 10.1177/11795468251369240. eCollection 2025.
2
Factors Predicting Myocardial Recovery After Hospitalization for De Novo Heart Failure with Reduced Left Ventricular Ejection Fraction: Results from the COMFE Registry.左心室射血分数降低的初发心力衰竭患者住院后心肌恢复的预测因素:COMFE注册研究结果
Biomedicines. 2025 May 8;13(5):1143. doi: 10.3390/biomedicines13051143.
3
Incidence and determinants of left ventricular ejection fraction (LVEF) recovery in heart failure with reduced ejection fraction (HFrEF) of non-ischemic aetiology; a hospital-based prospective longitudinal registry study.非缺血性病因的射血分数降低的心力衰竭(HFrEF)患者左心室射血分数(LVEF)恢复的发生率及决定因素;一项基于医院的前瞻性纵向登记研究。
Indian Heart J. 2025 May-Jun;77(3):188-192. doi: 10.1016/j.ihj.2025.03.016. Epub 2025 Apr 3.
4
Cardiomyopathies: The Role of Non-Coding RNAs.心肌病:非编码RNA的作用
Noncoding RNA. 2024 Oct 23;10(6):53. doi: 10.3390/ncrna10060053.
5
Clinical Perspective of Myocardial Recovery and Improvement: Definitions, Prevalence, and Relevance.心肌恢复和改善的临床视角:定义、流行率及相关性。
Methodist Debakey Cardiovasc J. 2024 Aug 20;20(4):6-15. doi: 10.14797/mdcvj.1441. eCollection 2024.
6
Genotype is associated with left ventricular reverse remodelling and early events in recent-onset dilated cardiomyopathy.基因型与近期发病的扩张型心肌病的左心室逆向重构及早期事件相关。
ESC Heart Fail. 2024 Dec;11(6):4127-4138. doi: 10.1002/ehf2.15009. Epub 2024 Aug 11.
7
Transient Left Ventricular Dysfunction from Cardiomyopathies to Myocardial Viability: When and Why Cardiac Function Recovers.从心肌病到心肌存活的短暂性左心室功能障碍:心脏功能何时恢复及为何恢复。
Biomedicines. 2024 May 9;12(5):1051. doi: 10.3390/biomedicines12051051.
8
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.2024 年心脏病与中风统计数据:美国心脏协会发布的美国和全球数据报告。
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
9
Clinical, Echocardiographic, and Longitudinal Characteristics Associated With Heart Failure With Improved Ejection Fraction.与射血分数改善型心力衰竭相关的临床、超声心动图和纵向特征。
Am J Cardiol. 2024 Jan 15;211:143-152. doi: 10.1016/j.amjcard.2023.10.086. Epub 2023 Nov 2.
10
Defining cardiac functional recovery in end-stage heart failure at single-cell resolution.在单细胞分辨率下定义终末期心力衰竭中的心脏功能恢复。
Nat Cardiovasc Res. 2023 Apr;2(4):399-416. doi: 10.1038/s44161-023-00260-8. Epub 2023 Apr 6.

本文引用的文献

1
Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors.曲妥珠单抗致早期乳腺癌患者心脏毒性的回顾性研究:可能的风险和保护因素分析。
Heart. 2013 May;99(9):634-9. doi: 10.1136/heartjnl-2012-303151. Epub 2013 Jan 24.
2
Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy.新发扩张型心肌病患者左心室逆重构的新预测因子。
J Am Coll Cardiol. 2013 Jan 8;61(1):54-63. doi: 10.1016/j.jacc.2012.07.072.
3
Myocardial recovery and the failing heart: myth, magic, or molecular target?心肌修复与衰竭心脏:是神话、魔法,还是分子靶点?
J Am Coll Cardiol. 2012 Dec 18;60(24):2465-72. doi: 10.1016/j.jacc.2012.06.062. Epub 2012 Nov 14.
4
Predictors of outcome in 176 South African patients with peripartum cardiomyopathy.176 例南非围生期心肌病患者结局的预测因素。
Heart. 2013 Mar;99(5):308-13. doi: 10.1136/heartjnl-2012-302760. Epub 2012 Oct 31.
5
Reversal of cardiomyopathy in patients with congestive heart failure secondary to tachycardia.继发于心动过速的充血性心力衰竭患者心肌病的逆转
J Interv Card Electrophysiol. 2013 Jan;36(1):27-32; discussion 32. doi: 10.1007/s10840-012-9727-9. Epub 2012 Oct 23.
6
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer.NSABP B-31 试验的 7 年心脏功能随访评估,该试验为随机试验,比较了多柔比星和环磷酰胺序贯紫杉醇(ACP)与 ACP 联合曲妥珠单抗用于治疗人表皮生长因子受体 2 阳性、淋巴结阳性乳腺癌患者的辅助治疗。
J Clin Oncol. 2012 Nov 1;30(31):3792-9. doi: 10.1200/JCO.2011.40.0010. Epub 2012 Sep 17.
7
Natural history, management, and outcomes of peripartum cardiomyopathy: an Irish single-center cohort study.围产期心肌病的自然病史、管理及结局:一项爱尔兰单中心队列研究。
J Matern Fetal Neonatal Med. 2013 Jan;26(2):161-5. doi: 10.3109/14767058.2012.726299. Epub 2012 Sep 25.
8
Subclinical myocardial dysfunction in patients with reverse-remodeled dilated cardiomyopathy.逆重构扩张型心肌病患者的亚临床心肌功能障碍。
J Am Soc Echocardiogr. 2012 Jul;25(7):726-32. doi: 10.1016/j.echo.2012.04.001. Epub 2012 Apr 24.
9
Update on myocarditis.心肌炎最新进展。
J Am Coll Cardiol. 2012 Feb 28;59(9):779-92. doi: 10.1016/j.jacc.2011.09.074.
10
Clinical characteristics and outcome of apical ballooning syndrome in Auckland, New Zealand.新西兰奥克兰地区心尖球囊综合征的临床特征和转归。
Heart Lung Circ. 2012 Mar;21(3):143-9. doi: 10.1016/j.hlc.2011.11.010. Epub 2012 Jan 10.